LGALS3 and atherosclerosis: Among the most promising candidates in this arena are galectin-3 and pentraxin-3, both of which have garnered significant attention for their roles in inflammation and atherosclerosis—two pivotal processes that underpin the pathophysiology of both CCS and AF [1,2,3].